[Beta 2 microglobulin in normal populations and populations at risk] NLM AIDSLINE Important note: Information in this article was accurate in 1985. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Beta 2 microglobulin in normal populations and populations at risk]

Rev Fr Transfus Immunohematol. 1984 Sep;27(4):531-6. Unique Identifier : AIDSLINE MED/85065387
Kadouche J; Pouletty P; Rosenbaum W; Courouce AM

Abstract: Quantitative analysis of beta-2-microglobulin (beta-2-M) may be a useful test for early diagnosis of acquired immuno-deficiency syndrome (AIDS). Even if beta-2-M is an unspecific marker, 96% of 45 patients with confirmed AIDS and 82% of 45 patients with lymphadenopathy have excessive (3 mg/l) beta-2-M value. beta-2-M is also useful in epidemiological studies, especially in subjects in close contact with patients, and in polytransfused hemophiliacs. At last, beta-2-M may be useful as a screening method in blood banks: from a study of 929 sera, excessive beta-2-M value was observed in 16 cases, which were excluded as blood donors.
Keywords: beta 2-Microglobulin/*ANALYSIS Acquired Immunodeficiency Syndrome/IMMUNOLOGY Blood Donors English Abstract Epidemiologic Methods Hemophilia/IMMUNOLOGY Homosexuality Human Lymphatic Diseases/IMMUNOLOGY Risk JOURNAL ARTICLE

KWDbeta2-microglobulin/KWDanalysisacquiredimmunodeficiencysyndrome/immunologyblooddonorsenglishabstractepidemiologicmethodshemophilia/immunologyhomosexualityhumanlymphaticdiseases/immunologyriskjournalarticle
850330
M8530098

Copyright © 1985 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1985. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1985. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .